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Abstract
The proper way to test the usefulness of hospitalization in syncope patients would be to conduct 
a randomized controlled trial. However, this approach is characterized by major theoretical 
and ethical limitations which make this procedure unfeasible. Data from observational studies 
indirectly show that hospitalization might help reduce the short-term risk of death and adverse 
events by promptly identifying and treating life-threatening events or conditions. Future research  
should focus on identifying which patients will benefit from hospitalization. In this regard,  
we should be able both to correctly risk-stratify patients and to analyze syncope observation 
units and protocols, which may provide a safe alternative for the evaluation of intermediate-
-risk patients. (Cardiol J 2014; 21, 6: 606–610)
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Introduction
Two patients presented to the Emergency 
Department (ED) with syncope.
The first was a 72-year-old man, complain-
ing of syncope without prodromes. He had had 
2 syncope episodes in the last week. The first one 
happened while he was standing at the supermar-
ket. The second episode occurred while he was 
walking and resulted in head trauma. Head compu-
ted tomography scan was unremarkable; his elec-
trocardiogram (ECG) showed a previously known 
left bundle branch block. The medical history was 
consistent with a previous (5 years before) myocar-
dial infarction with preserved ejection fraction. His 
medical therapy included angiotensin-converting 
enzyme inhibitor, beta-blocker, aspirin, statin.
The second patient was a 20-year-old woman 
who fainted while standing at a concert. Syncope 
was preceded by prodromes (blurred vision).
Which patient needed or would benefit from 
hospital admission?
In this paper, we will address the question 
whether hospitalization may reduce adverse events 
after syncope.
Effectiveness of hospital  
admission in syncope patients:  
Methodological considerations
From a methodological point of view, the best 
answer to the above question would be furnished by 
a randomized controlled trial (RCT). A hypothetical 
trial could be designed in two different ways: 
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1. All patients presenting with syncope to the 
ED could be randomized to hospital admission/ 
/discharge to assess hospitalization’s impact 
on the outcome; 
2. Only high and intermediate risk patients could 
be randomized in a similar trial. 
In the first case, the young woman might be 
admitted, in contrast to the usual clinical practice 
and common sense. In the second case, we would 
decide a priori to exclude the young girl from ran-
domization, however, are we sure that she would 
not gain any benefit from hospital admission? Mo-
reover, in both cases, the man could be randomly 
put in the discharge arm of the trial. Do we think 
that such an approach would be ethical?
In 2003, Gordon Smith and Jill Pell published 
a systematic review in BMJ [1] concerning the 
potential use of parachute to prevent death and 
major trauma related to the gravitational challenge. 
They concluded that, similar to many interventions 
intended to prevent illness, so far the effectiveness 
of parachutes had not been subjected to rigorous 
evaluation by using randomized controlled trials. 
Since advocates for evidence based medicine have 
criticized the adoption of interventions evaluated 
by using only observational data, the authors sug-
gested that they could organize and participate 
themselves in a double blind, randomized, placebo 
controlled, crossover parachute trial.
Among the dozens of letters to the Editor 
concerning this article, Victor Montori [2] reported 
that 2 friends of his had decided to conduct the RCT 
suggested by Smith and Pell [1]. The volunteer with 
the parachute survived, while the other person, 
randomized to parachute off, died due to the ground 
impact. The survivor was psychologically devasta-
ted (felt worse than being dead) and killed himself 
3 months later. The author concluded that the 100% 
reduction in the risk of dying on impact is clearly 
valid and convincing. However, there was no diffe-
rence in 3-month mortality between the two study 
arms. In addition, the quality of life seemed worse 
for the subject in the parachute arm of the study. 
Coming to the real purpose of the letter, Montori 
wanted to highlight that RCTs are useful only if there 
is equipoise between the two treatments. If good 
observational studies had already proven the utility 
of parachute, it would be unethical to do a RCT.
Evidences of effectiveness of hospital  
admission in syncope patients
If syncope etiology is identified during ED 
stay, the patient will be managed according to the 
underlying condition. For example, if pulmonary 
embolism (PE) is the cause of syncope, the patient 
will be admitted or discharged according to his PE 
risk profile [3] and syncope prognosis will be defi-
ned by the PE. Conversely, if a vasovagal cause of 
syncope is confirmed, the patient will be discharged 
unless his frailty or social condition requires an 
admission. The problem arises for those patients 
in whom a proper diagnosis cannot be provided 
in the ED. Notably, these patients represent up 
to 30–50% of ED syncope patients [4, 5]. Does 
hospitalization reduce the risk of adverse events 
in this population?
There is no direct answer to this question but 
indirect evidence can be obtained. A recent study 
reported that the risk of adverse events in admitted 
patients is fairly low [6]. However, others repor-
ted that the risk of adverse events in discharged 
patients is not negligible [7] and may be as high as 
9.7% at 30 days. Considering all the prospective 
studies on syncope in the ED, the risk of 10-day 
adverse events is highly heterogeneous, spanning 
between 5% and 20% [8]. The 30-days risk of death 
was reported to be as high as 5% [9].
It is important to point out that hospitalization 
could be useful for three different reasons: 
1. It may reduce the risk of death and adverse 
events in the short term. This is achieved by 
monitoring the patient, so that an adequate 
therapy can be promptly instituted in case of 
life-threatening events. 
2. It may help to obtain an early diagnosis that 
could be otherwise impossible, thus potential-
ly reducing adverse events in the long-term 
period.
3. It may allow treatments that cannot be done 
without hospital admission, such as pacemaker 
or implantable cardioverter-defibrillator (ICD) 
implantation.
Notably, the decision to admit a patient should 
also take into account the possible adverse events 
related to the hospitalization itself. Therefore, this 
risk should be smaller than the overall benefit gai-
ned by the diagnosis and therapy [10]. However, in 
spite of a number of clinical decision tools to assess 
the risk of adverse events [11–14], it is difficult 
to set up a decision threshold for hospitalization.
The Short-term Prognosis of Syncope (STePS) 
study [15] was specifically designed to test if hospi-
talization could be useful in patients with syncope. 
More than 650 patients were prospectively enrolled 
in 4 Italian EDs in 2004. The authors addressed the 
problem of the usefulness of hospital admission in 
patients with syncope by two different approaches.
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1. First, they considered the number of major 
therapeutic procedures (namely pacemaker 
or ICD insertion, cardiopulmonary resuscita-
tion, admission to intensive care unit, acute 
anti-arrhythmic therapy), hospital readmission 
for syncope and death in both admitted and 
discharged patients. They assumed that if 
one of these procedures had been done during 
hospitalization, then the hospital admission 
itself would have been useful. In addition, if the 
death rate had been similar between admitted 
and discharged patients then we could spe-
culate if these procedures would have saved 
some lives. Indeed, while in the short-term 
period major therapeutic procedures were 
14.7% and 2% in the admitted and discharged 
patients, respectively (p < 0.01), death rates 
were similar (1.4% vs. 0.4%, p = NS) in both 
populations. This suggests that major thera-
peutic procedures saved lives and that hospital 
admission was effective for those patients. 
However, it must be highlighted that, although 
the study was underpowered to detect death 
rate differences between the two groups, 
a 15% rate of major therapeutic procedures in 
the admitted patients suggests that the death 
rate could have been higher if these patients 
would have been discharged.
2. The second way to test whether or not hospi-
talization might be useful was to compare risk 
factors for short- and long-term outcomes and 
the long-term prognosis between admitted 
and discharged patients. Interestingly, the 
risk factors for short- and long-term outcomes 
differed. While short-term risk factors (abnor-
mal ECG, trauma, absence of prodromes, male 
gender) were probably related to the severity 
of the syncopal episode, the risk factors for 
long-term outcomes (age > 65 years, neo-
plasms, cerebrovascular diseases, structural 
heart diseases, ventricular arrhythmia) se-
emed more related to the frailty of the patient. 
Indeed, the rate of adverse events at 1 year 
was higher in the admitted patients than in the 
discharged ones (Fig. 1). The same conclusion 
was also suggested by the EGSYS 2 follow-up 
study [16] and by Kapoor and Hanusa [17]. 
The latter was a prospective cohort study of 
patients with syncope matched to a group of 
patients without syncope according to age, 
gender, site of care (inpatient/ outpatient) and 
cardiac diseases. Patients with and without 
syncope had similar rates of cardiovascular 
outcomes, 1-year overall and cardiac mortality. 
Predictors of death were male gender, age 
> 55 years, and congestive heart failure, 
thus showing that underlying heart diseases 
and patient’s vulnerability are risk factors for 
long-term mortality regardless of the presence 
of syncope.
In summary, since the syncope 30-day death 
rate is not negligible and might be prevented by 
some lifesaving procedures, we do believe that the 
question is no more if hospital admission is useful 
for syncope patients but in whom hospitalization 
can be effective.
The hospitalization rate vary largely world-
wide, spanning between 10% and 90% [8, 9], and 
being about 35% in the STePS study.
The first international workshop on syncope 
risk stratification was held in Gargnano, Italy, in 
September 2013. Discussants from all over the 
world were asked to anonymously declare which 
rate of hospitalization they considered appropriate 
for patients with unexplained syncope. Most of the 
experts asserted that the appropriate admission 
rate would be less than 30%. Since about 50% of 
syncope patients receive a diagnosis in the ED [18], 
this means that the optimal rate of hospitalization 
should be around 15% of all patients who present 
to the ED because of syncope.
Thus, the correct approach for loss of conscio-
usness management in the ED, after recognizing 
it as syncope, should be to focus on a correct 
etiopathogenetic diagnosis. If the diagnosis is 
reached, the patient will follow its management 
Figure 1. One year survival curves of admitted and 
discharged patients from the STePS study [15]. Notice 
that survival was significantly lower in admitted patients 
(p < 0.0001). This apparently confounding finding stems 
from the fact that admitted individuals were older and 
more sick.
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strategy unless the presence of frailty or comor-
bidities requires a different approach. If syncope 
remains unexplained, a decision about admission or 
discharge is more complex and patients will need 
a proper risk stratification to recognize those who 
deserve hospital admission [19].
Currently, no prediction tool can replace an ade-
quate clinical judgment about the decision whether 
to admit or discharge patients who are neither at 
high nor at low risk [8, 20, 21]. The most promising 
way to improve management strategies that could 
safely reduce hospitalization rates is probably the 
development of observation units and syncope 
unit protocols [19, 22]. Two randomized trials 
compared standard care and 6 h [23] or 12 h [24] 
structured ED-based observation protocols in 
intermediate risk patients. Results showed that 
ED syncope units/protocols can reduce hospitali-
zations, length of stay, and costs without apparent 
effect on serious clinical events, quality of life, and 
patient satisfaction. However, both studies enrolled 
a limited number of patients and additional work is 
needed to definitively demonstrate the safety and 
efficacy of such an approach.
Another important issue indirectly affecting 
the decision to hospitalize is to establish which is 
the most suitable ward to admit the patient. Since 
the aim of hospitalization is to early diagnose and 
treat life-threatening conditions (such as arrhyth-
mias), syncope patients should be admitted in 
a continuous ECG-monitored bed.
Direction for future researches
The ideal way to test the usefulness of hospi-
talization in syncope patients would be to conduct 
a RCT, however this approach doesn’t seem to be 
appropriate in this setting. Indeed, data from ob-
servational studies show that the rate of adverse 
events in non no-risk patients is too high to safely 
randomize them to discharge. However, data from 
observational studies indirectly show that hospi-
talization might help reduce the short-term risk of 
death and adverse events by promptly identifying 
and treating life-threatening events or conditions.
In our opinion, research must focus on iden-
tifying which patients will benefit from hospitaliza-
tion, namely who will have more benefits (adverse 
events avoided, potential life-threatening diagnosis 
provided and useful treatments established) than 
harms from admission. To answer this question, we 
should be able to correctly risk-stratify patients. 
Identifying “no-risk” patients would be the best for 
emergency physicians. However, no-risk patients 
are likely to be young and healthy individuals who 
have a presumptive vasovagal mechanism; iden-
tification of such patients is unlikely to improve 
practice since they are almost never admitted. 
A true “zero risk” is probably impossible to reach 
in patients for whom there is currently uncer- 
tainty about clinical management. A more reaso-
nable approach could be to find the way to assess 
patient’s risk as a continuum, so that physicians 
working in different clinical settings can decide 
which threshold to adopt for admitting patients.
A second step will be to analyze syncope ob-
servation units and protocols, which may provide 
a safe alternative for the evaluation of intermediate-
-risk patients. In this regard, we believe that more 
evidence is needed. Since randomized evaluation of 
health services interventions may not be feasible, 
alternative evaluation designs might include ran-
domized cluster trials, randomized registries, and 
evaluation of natural experiments (e.g., pre-post 
intervention with control) [19].
Conclusions
The proper way to address the problem of the 
effectiveness of hospital admission after syncope 
would be to do a RCT. However, this approach 
is characterized by major theoretical and ethical 
limitations which make this procedure unfeasible. 
Although indirect, there is enough evidence that 
hospital admission may be effective in some pa-
tients with syncope.
The main issue dealing with syncope in the ED 
is to identify the patient who needs hospitalization. 
The best strategy to manage these patients (obser-
vation unit, syncope unit, short admission, outpa-
tient monitoring systems) is still under evaluation.
The worldwide rate of hospitalization for 
syncope is very heterogeneous and presently it is 
likely that an excessive number of patients with 
syncope are admitted to hospitals. Future research 
should compare different management strategies 
and find the best risk stratification tool for syncope 
patients.
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